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METHODOLOGY Open Access
Defining and evaluating novel procedures
for involving patients in Core Outcome Set
research: creating a meaningful long list of
candidate outcome domains
Harriet Smith1,2, Adele Horobin1,3, Kathryn Fackrell1,2, Veronica Colley1, Brian Thacker1, Deborah A. Hall1,2,3* and for
the Core Outcome Measures in Tinnitus (COMiT) initiative
Plain English summary
Outcome domains are aspects of a condition that matter to patients and clinicians and can be measured
to assess treatment effects. For tinnitus, examples include ‘tinnitus loudness’ and ‘ability to concentrate’. This study
focuses on the first stage of agreeing which outcome domains should be measured in all clinical trials of tinnitus.
Crucially, it involves identifying outcome domains, prior to a voting process. This article describes how we effectively
involved patients in that study design process, and reflects on the impact of their input.
The study first compiled a long list of all possible outcome domains before asking interested parties,
including patients, to vote which ones to include. Ensuring patients fully participate in this process holds
unique challenges as it can be long, repetitive and its purpose far removed from their needs. These challenges
may be addressed by involving patients in designing the research. There is evidence that other research
teams are doing this, but its reporting is not detailed enough to guide others. Our paper seeks to address
this.
We describe how we involved patients (people living with tinnitus) in creating a long list of outcome domains that
we included in our study. We also reflect on the benefits this brought. Two patients partnered with us in designing
the survey. We also consulted an independent patient review panel. Involving patients reduced the list of domains
included in the survey and made domain names and associated descriptions clearer. Our resulting survey performed
well in recruiting and retaining patients as participants.
Abstract
Background Tinnitus is a complex audiological condition affecting many different domains of everyday life.
Clinical trials of tinnitus interventions measure and report those outcome domains inconsistently and this
hinders direct comparison between study findings. To address this problem, an ongoing project is developing
a Core Outcome Set; an agreed list of outcome domains to be measured and reported in all future trials.
Part of this project uses a consensus methodology (‘Delphi’ survey), whereby all relevant stakeholders identify
important and critical outcome domains from a long list of candidates. This article addresses a gap in the
patient involvement literature by describing and reflecting on our involvement of patients to create a meaningful long
list of candidate outcome domains.
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Methods Two Public Research Partners with lived experience of tinnitus reviewed an initial list of 124 outcome domains
over two face-to-face workshops. With the Study Management Team, they interpreted each candidate outcome domain
and generated a plain language description. Following this, the domain names and descriptions underwent an
additional lay review by 14 patients and 5 clinical experts, via an online survey platform.
Results Insights gained from the workshops and survey feedback prompted substantial, unforeseen modifications to the
long list. These included the reduction of the number of outcome domains (from 124 to 66) via the exclusion of broad
concepts and consolidation of equivalent domains or domains outside the scope of the study. Reviewers also applied
their lived experience of tinnitus to bring clarity and relevance to domain names and plain language descriptions. Four
impacts on the Delphi survey were observed: recruitment exceeded the target by 171%, there were equivalent numbers
of patient and professional participants (n = 358 and n = 312, respectively), feedback was mostly positive, and retention
was high (87%).
Conclusions Patient involvement was an integral and transformative step of the study design process. Patient involvement
was impactful because the online Delphi survey was successful in recruiting and retaining participants, and there were
many comments about a positive participatory experience. Seven general methodological features are highlighted which
fit with general principles of good patient involvement. These can benefit other Core Outcome Set developers.
Keywords: Tinnitus, Outcome domains, Delphi survey, Public research partners, Reducing, Consolidating, Modifying
Background
The core outcome measures in tinnitus (COMIT) initiative
This methodology article is based on experience involv-
ing the public in the COMIT’ID study. COMIT’ID
stands for ‘Core Outcome Measures in Tinnitus – Inter-
national Delphi’ and used a modified Delphi survey to
seek consensus between different stakeholder groups
about what outcome domains are critically important
when deciding if an intervention for tinnitus is working.
The COMIT (Core Outcome Measures in Tinnitus)
initiative is led by members of the European TINnitus
NETwork (TINNET) to develop standards for clinical
trials in tinnitus [1, 2]. A core outcome set establishes
standards for outcome selection and reporting in clinical
trials of interventions to improve the wellbeing of people
with this lifelong condition. An outcome can be viewed
in two parts. First, the outcome domain refers to what
aspects of tinnitus matter to patients and clinicians. Out-
come domains refer to any aspect of tinnitus that is or can
be experienced by a patient, such as ability to concentrate,
sense of control, or impact on work. Second, the outcome
instrument refers to how that domain is to be measured.
Throughout this report, the term “outcome” refers to the
general construct which includes both concepts of what
and how to measure, while the term “outcome domain” or
“domain” is restricted to the concept of what to measure.
The list of critically important outcome domains - known
as a Core Outcome Set (COS) - forms a minimum set of
outcome domains that should be measured and reported
in every clinical trial [3, 4]. A minimum set means that
researchers must report on the same core outcome
domains, whilst remaining free to collect and explore other
outcomes too. COMIT’ID aims to develop three separate
COSs for tinnitus: one for sound-based intervention out-
come domains; one for psychology-based intervention
outcome domains; and one for pharmacology-based inter-
vention outcome domains. These COSs will be relevant for
adults with chronic subjective tinnitus that should be
measured and reported in every clinical trial of these inter-
ventions [5]. The long-term goal is to standardise what
is measured when sound-based, psychology-based, or
pharmacology-based tinnitus interventions are tested, so
that data can be compared or combined across studies.
There are different ways that patients can be involved in
the process of designing, running and disseminating a
COS study. While the term “patient” typically refers to a
person who is receiving or registered to receive medical
intervention, “patient” is used here to refer to anyone who
has lived experience of tinnitus. This article documents a
set of methods for involving patients in creating the long
list of tinnitus-related outcome domains for round 1 of
the Delphi survey. These methods form the first stage of
the consensus process to create the three COSs. The
article also reflects on the impact of that particular in-
volvement. Patients who took this role are referred to
throughout as ‘Public Research Partners’, although others
may use terms such as ‘advocates’, ‘representatives’, ‘contrib-
utors’, ‘surrogates’ or ‘community stakeholders’ etc. [6, 7].
Why are core outcome sets (COS) needed for tinnitus?
Tinnitus is a subjective condition for which patients
experience a diversity of complaints. Hence, there is no
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straightforward outcome. Some tinnitus outcomes are
specific (for example, the perceived pitch of the tinnitus)
while others are broad (for example, tinnitus-related
quality of life). One of the challenges is that different
studies evaluating interventions for tinnitus often meas-
ure and report different outcomes [8]. This makes it very
difficult to compare results between studies. What is
urgently needed are specific discussions around the
major therapeutic approaches for tinnitus (namely sound
therapies, psychological interventions, and pharmaco-
logical therapies) because they do not necessarily target
the same tinnitus-related complaints [2, 5]. For example,
if all sound-based intervention studies reported the same
outcomes, then all the results could be compared and
combined. A methodological consensus regarding what
aspects of tinnitus should be measured would help to
make sense of all the knowledge produced and thus
improve the rate of progress in developing interventions
[2]. In addition, involving patients in developing these
outcome reporting standards would go a long way to
ensuring its relevance to end users [2, 5].
Defining candidate outcome domains
Defining a COS involves working with various stake-
holders, such as health care users, health care practi-
tioners and commercial representatives, to prioritise
large numbers of outcome domains and achieve con-
sensus about the minimum set. Various methods have
been used to identify important outcomes when de-
veloping a health care COS and there is insufficient
evidence to determine which is the most appropriate
or efficient [9]. Delphi survey methods are one of the
most frequent approaches used [9]. In a conventional
Delphi survey, participants nominate outcomes in
round 1 to be considered in subsequent rounds, but a
modified Delphi survey is becoming a popular way to
reduce the burden to participants [9, 10]. In a modi-
fied Delphi survey, a comprehensive list – called a
‘long list’ – of all possible outcomes is first identified
through a scoping process such as a systematic review
of previous clinical trials, and/or patient-centred re-
sponses collected through interviews or focus groups.
This long list forms the first of several rounds in
which participants rate the importance of each and
every outcome [9, 11]. As part of round 1, it is gener-
ally recommended that participants be given oppor-
tunities to suggest new outcomes which they think
are missing and submit feedback or personal perspec-
tives about specific outcomes [3, 9, 10]. This enables
the team to be confident that they are representing
the perspectives of all relevant stakeholder groups
and to gain a greater understanding of why a particu-
lar outcome might be deemed important.
Procedures for involving patients in COS development
From a series of discussion-based workshops with
patients, Young and Bagley [7] reported on how includ-
ing patients as participants and as Public Research
Partners holds unique challenges. Workshop delegates
advised that Public Research Partners have an important
role in developing clear explanations of COS and associ-
ated concepts because these can seem far removed from
the experience of patients. Delegates also cautioned that
the long list of candidate outcome domains found in
some Delphi surveys can be off putting for many patient
participants, and so Public Research Partners can again
play an important role in highlighting this risk and help-
ing to work out ways to minimise its occurrence. If not
adequately addressed at the study design stage, these
challenges could have a negative impact on accessibility
of the Delphi survey to patients. Indeed, low rates of
recruitment have been reported in a previous hearing-
related COS [12, 13]. Increasingly, taking a patient-
centred approach can improve the relevance and interest
to patients. There is recent evidence that investigators
are incorporating public involvement in a variety of
different stages of COS development. Examples include
appointing Public Research Partners to the Project Steer-
ing Group [14], reviewing and reducing the long list [14,
15], reviewing and suggesting new outcomes for the long
list [16], deciding the outcome name [17], creating a
plain language description for each outcome domain to
ensure all participants interpret concepts as intended [18,
19], creating age-appropriate outcome domain descriptions
with children and parents [20], creating ‘lay equivalents’ for
a public version of the survey, different from the profes-
sional version [21], and piloting the Delphi survey for ac-
cessibility [16, 18, 22–24].
Despite these positive advances in COS methodology,
Young and Bagley [7] found that published reports did
not always clearly distinguish between public participa-
tion and involvement. Furthermore, while published
protocols broadly state which steps of the process the
public are to be involved, they generally do not provide
any in-depth detail on the procedures to be used and the
anticipated benefits to be gained [16–21, 23]. As such,
Gargon and colleagues [25] conclude that there is a need
for greater methodological guidance in how to effectively
involve the public in COS development, while Jones and
colleagues [26] have called for further research about the
impact of these forms of public involvement. An illustra-
tive example of good reflective practice is shown by
Bruce and colleagues [13]. Their COS study presented
plain language descriptions of outcome domains for the
public participants only, not the professional stake-
holders. However, the consensus meeting identified some
domain names which had been ambiguous in meaning to
the professional Delphi participants indicating that in
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future studies the plain language descriptions should be
available to all.
Aim
When designing the COMIT’ID study, no published
procedures were found which described exactly how
Public Research Partners have been involved in creating a
long list of candidate outcome domains for a round 1
Delphi survey, nor evaluation of its impact. This method-
ology article addresses this gap in knowledge by reporting
in detail our procedures to involve two Public Research
Partners. The article also reflects on and evaluates the
benefits of this form of public involvement. In so doing,
the evidence contributes to the sharing of good practice in
public involvement in developing COS. To further en-
hance the quality, transparency, and consistency of the
PPI evidence base for public involvement in core outcome
set development, reporting is guided by the GRIPP2-SF
checklist [27].
Methods
The Study Management Team comprised three tinnitus
researchers (HS, KF, DAH). Public involvement was
delivered by a dedicated team of two Public Research
Partners with lived experience of tinnitus (VC, BT) and
a Patient and Public Involvement and Engagement Man-
ager (PPI/E Manager, AH). All the Study Management
Team was also part of the wider COMIT’ID Research
Steering Group that included three physicians from
France, Germany, and Portugal. Independent lay reviews
were provided by 14 members of the British Tinnitus
Association’s Users’ panel, again all with lived experience
of tinnitus, and five clinical experts who were members
of the British Tinnitus Association Professional Advisory
Committee. To improve the appeal to healthcare users
and to reduce attrition, the two Public Research Partners
additionally commented on the feasibility of the Delphi
survey design, and reviewed study documentation
(advertisements, Information Sheets, video instructions
for the survey). Because these procedures for public
involvement are not the focus of the current article, they
are not reported further. All planned public involvement
activities were described in the project protocol (version
2, dated 13 March 2017) which was approved by the
West Midlands - Solihull Research Ethics Committee
(reference 17/WM/0095) on 21 March 2017.
The Study Management Team first sought to create a
comprehensive list of all possible outcome domains
relevant to tinnitus, regardless of intervention type. A
common long list of outcome domains was therefore cre-
ated for round 1 of all three Delphi surveys (sound, psych-
ology and drug-based interventions). The researchers first
identified 169 potential candidate outcome domains via: i)
a systematic review of outcome domains reported in
clinical trials of tinnitus interventions in adults (62 out-
come domains) [8], ii) a thematic analysis of the items
taken from 23 commonly reported patient-reported ques-
tionnaire instruments for tinnitus (64 outcome domains)
[Fackrell, personal communication], and iii) a systematic
review of dimensions of tinnitus-related complaints re-
ported by patients and their significant others using ques-
tionnaire- and interview-based methods (43 outcome
domains) [28]. The Study Management Team were able to
reduce this list to 124 candidate outcome domains by con-
solidating domains that were literal duplicates of one
another (see Fig. 1). Two members of the Study Manage-
ment Team (HS, KF) and our two Public Research Part-
ners (VC, BT) and PPI/E Manager (AH) then participated
in two half-day workshops, with the initial objective to re-
view the list of domains identified by the scoping exercise
and their associated plain language descriptions; specific-
ally to comment on the readability of the domain descrip-
tions and on the suitability of the headings under which
outcome domains were grouped. The team was motivated
by the need to describe domains so that all participants,
including patients, interpreted the meanings clearly and
consistently across stakeholder groups. Also, that having
English as an additional language would not act as a bar-
rier to comprehension, given the international focus of the
COMIT’ID study. Discussion focussed on the outcome
domains themselves, not on their potential relevance to
any sound-based, psychology-based, or pharmacology-
based intervention.
In preparation for these workshops, and to create a
starting point for discussion, the Study Management
Team compiled preliminary plain language descriptions
taken from the systematic reviews and content analysis,
and from searches of the Oxford English Dictionary [29].
The Public Research Partners were encouraged to
explain what each outcome domain name meant to
them and then suggest a way to describe it using lan-
guage that would be accessible to other members of the
public. A harmonised plain language description had to
have approval from both Public Research Partners and
the researchers, before moving the discussion to the next
domain. Although domains were presented one by one,
there was cross-referencing to previously discussed
domains where needed. Each workshop was audio
recorded for later reference. Handwritten notes to aid
discussion were encouraged and the two researchers
wrote down the plain language description as well as any
strong opinions or concerns voiced by either Public
Research Partner. Such insights led to a number of
unforeseen decisions about the long list of outcome
domains for the round 1 Delphi survey.
The public involvement work with the two Public
Research Partners was then supplemented with inde-
pendent reviews conducted by 14 members of the public
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with tinnitus recruited from the British Tinnitus Associ-
ation Users’ Panel. These reviewers responded to an
invitation emailed to 30 members of the panel. Re-
viewers were naïve to the details of the COMIT’ID
study, but were nevertheless experienced Lay Reviewers.
Here, outcome domain names, plain language descrip-
tions and category labels that had been developed for
each domain in the modified long list were presented to
Lay Reviewers using an online survey platform (Survey
Monkey), with the option for free text responses about
each domain. For each plain language description, Lay
Reviewers were asked to select whether it was “a clear
and understandable definition (no changes needed)” or
not. If not, then they were asked to explain why and sug-
gest alternative words or phrasing. Lay Reviewers were
also asked to review the outcome domain category la-
bels. For each outcome domain, Lay Reviewers were
asked to select whether it “fit in this category” or not. If
not, then they were asked to explain why and suggest an
alternative category.
This yielded further insights which informed the final
version of the long list for round 1 of the Delphi survey.
Results
The 124 outcome domains from the scoping process
were presented to the Public Research Partners and PPI/
E Manager for generating plain language descriptions,
and these were then reviewed by expert Lay Reviewers.
The initial impression of the Public Research Partners
was that the original long list was so long it was not user
friendly, and their concerns were that this would
negatively impact on recruitment and on sustained
respondent engagement across the three survey rounds.
This insight prompted the Study Management Team to
critically rethink the composition of the long list leading
to decisions to modify it in a number of radical, but
unforeseen, ways. Illustrative examples of changes made
to the long list of candidate outcome domains as a direct
result of public involvement are reported below.
Fig. 1 Flow diagram illustrating the pre-Delphi stage that was completed with the involvement of healthcare users as Public Research Partners
prior to round 1 of the modified Delphi survey. Taken from Fackrell et al. [5]
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Reducing the long list
The most notable unforeseen impact of the public
involvement insights was to shorten the initial long list.
It was reduced by 57 outcome domains leaving a final
long list of 66 distinct, tinnitus-related domains. Overall,
36 domains were excluded, and 21 were pooled (i.e. con-
solidated) (see Fig. 1) either through direct recommen-
dation by the Public Research Partners, or through
Study Management Team discussion following the
workshops.
The input of the two Public Research Partners had the
greatest impact on the final content of the long list. Sub-
sequent comments made by the Lay Reviewers led to
only two further reductions in the number of candidate
domains (see Fig. 1).
Excluding broad concepts captured by other outcome
domain concepts
The Public Research Partners argued that 13 outcome
domains were broad concepts whose meaning was
already encapsulated by other domains in the long list
(Fig. 1). In one example, the general domain ‘cognitive
difficulties’ was deemed to be covered by the more spe-
cific domains: ‘concentration’, ‘tinnitus-related thoughts’,
‘confusion’, and ‘ability to ignore’. For example, on ‘tin-
nitus-related thoughts’, BT said “Thoughts about your
tinnitus…Thoughts about tinnitus...’cause that basically
is the cognitions”. In a second example, ‘health-related
quality of life’ was deemed to be part of ‘impact on rela-
tionships’, ‘impact on individual activities’, ‘impact on so-
cial life’, ‘impact on work’, and ‘sexual difficulties’.
Such overlap in meanings was considered to risk caus-
ing confusion when rating the importance of individual
outcome domains in the modified Delphi survey. To
minimise this risk, the Public Research Partners recom-
mended that such broad concepts should be removed
from the long list and instead used as a category label
for grouping similar domains together for presentation
in the modified Delphi survey.
Consolidating equivalent outcome domains
The Public Research Partners considered that three fear-
related concepts (‘Fear for health’, ‘Fear for quality of life’
and ‘Fear of tinnitus becoming worse’) could not easily
be distinguished from one another. For example, the dis-
cussion of the domain ‘fear for quality of life’, cross-
referenced back to the domain ‘fear for health’. BT said
“That’s so close to that one. It’s the same question asked
in a different way.” and VC said “When you look at it
later, you’ll be able to see if it’s turned out similar to
something else or one of them is more defined than an-
other”. As a consequence, these candidate domains were
consolidated into a single overarching health-related
concept, named ‘fear’ (Fig. 1). The plain language de-
scription was expanded to include all concepts (includ-
ing fear for health, now and in the future and fear of it
getting worse).
Similar comments made by Public Research Partners
and Lay Reviewers also prompted the consolidation of
the domain ‘bothered’ with ‘annoyance’. For example,
VC said “Do we need all of these?... Is annoying disrup-
tive? As much as disruptive isn’t it?...Disturbing.” Three
Lay Reviewers said “What's the difference between being
'annoyed' and being 'bothered'? In fact, what, specifically,
does 'bothered' mean?” and “Questions 29 [tinnitus
annoyance] and 30 [bothered] feel very similar to me,
and difficult to distinguish between them clearly.” and
“What's the difference between this, 'annoyed' and 'both-
ered' - and 'irritable' in the later aspect?”. The plain lan-
guage description for ‘annoyance’ was expanded to
include elements of bothered (i.e. knowing tinnitus is
there and finding it a nuisance).
Lay Reviewers also considered ‘frustration’ to share
important conceptual similarities with ‘upset’ and as a
consequence, ‘frustration’ was consolidated with ‘upset’.
Their feedback also prompted us to change the plain
language description for ‘upset’ to more closely match
the definition given in the Oxford English Dictionary
[Oxford English Dictionary, 2017]. The Study Man-
agement Team was satisfied that this new description
also encapsulated aspects of the associated concept
‘frustration’.
Consolidating outcome domains that define how the
domain might be measured
A number of outcome domains were judged to relate
more directly to how an outcome domain could be
measured. For example, an ‘active task to distract or
cope with tinnitus’ and ‘purposefully protecting or
reducing the chance of potential problems’ were both
considered different ways to measure the same health
construct ‘coping’. This recommendation from the
Public Research Partners resulted in ten outcome
domains being consolidated in the final version of the
long list under existing outcome domains ‘tinnitus loud-
ness’, ‘tinnitus quality’, ‘coping’, and the category ‘body
structures and functions’.
Modifying outcome domain names
Discussion with the Public Research Partners’ highlighted
ambiguities in meaning and awkwardness of repeated lan-
guage for some outcome domain names, particularly in
the ‘health-related quality of life’ category (see Table 1).
In one example, they spoke about how group-based
activities present very different challenges compared
with individual activities. As a result, the domain
name was modified to emphasise the individual
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nature of the activities in question (Table 1). A tran-
script of part of the discussion about the outcome
domain named ‘interference on activities’ is reported
below:
VC: “An activity sounds physical doesn’t it, rather
than…”
BT: “So a social”
VC: “Gathering”
BT: “Gathering, because that could be anywhere”
VC: “That could be restaurant, pub, party”
VC: “If you’re asking people for an honest reaction
to how much it interferes with their activities, there
are two very different things. One is on a one-to-one
erm social activity with somebody and the other is
a group gathering or activity with people…It’s much
easier to control the one-to-one…”
In a second example, there was discussion about the
term ‘interference’ and its repeated usage which led to
its substitution with the term ‘impact’ (Table 1):
VC: “Isn’t it, rather than interfere…Interfere is quite a
negative word isn’t it?”
KF: “Well yeh, we try to use impact over interfere
because impact can be… its more posi…, so you can
have a positive impact and a negative impact…”
VC: “Yeh”
KF: “…Whereas interfere just comes across as...”
VC: “Very negative”
KF: “It’s negatively interfering with something”
HS: “Effecting or impact would be quite neutral”
Modifying the plain language descriptions
Table 2 reports three illustrative examples of how input
from patients informed changes in our descriptions to
make them more understandable and relevant. Lay
Reviewer comments were especially informative for
understanding how other people interpreted the out-
come domains according to the plain language descrip-
tions that had been co-created by the Public Research
partners and the Study Management Team. For a num-
ber of domains, Lay Reviewers’ suggestions prompted us
to add more examples to widen the range of possible
experiences or scenarios. Inviting feedback from a wider
group, with a more diverse range of lived experiences
with tinnitus, enabled us to enhance the personal rele-
vance of our descriptions.
Potential impact on the round 1 Delphi survey
Although it is not possible to directly attribute study
performance to the public involvement described above,
the online Delphi survey was successful in recruiting
and retaining participants. Evidence indicates that partic-
ipants from a diverse range of backgrounds had positive
experiences of taking part.
High participant recruitment
Recruitment exceeded expectations. Although recruit-
ment was open for only a 14-week period (April–July
2017), it surpassed the target of 420 experts [5], with
719 participants consenting and 670 completing round 1
of the Delphi surveys. The COMIT’ID Delphi survey
appealed equally to patients (n = 358) as well as to pro-
fessionals (n = 312). This contrasts with a number of
other COS studies which have recruited markedly lower
numbers of patients compared to professionals (e.g. [14,
23, 30, 31]).
Positive participatory experience
Accessibility of the Delphi survey is illustrated by the
following selection of feedback quotes given by patients:
SOUND00016: “It took a little while for me to
understand the concept but once I got it; it was fine.”
SOUND00078: “Very good questions. I did not know
that what I have been thinking so long was even real;
or just real for me.”
TALKC00200: “Straight forward to complete.”
DRUGC00051: “Easy to understand and follow. Ready
for the next round.”
Following the GRIPP2-SF checklist [27], consideration
was also given to any negative participatory experiences.
Table 1 Illustrative examples of modifications to the outcome
domain names for domains in the ‘health-related quality of life’
category
Original outcome domain name Modified outcome domain name
Interference on social activities Impact on social life
Interference on work activities Impact on work
Interference on activities Impact on individual activities
Interference on relationships Impact on relationships
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These were relatively few, but some participants
expressed general difficulties in understanding some of
the outcome domain concepts, with comments including
the following:
SOUND00064: “I'm not sure I understand the subtle
distinction between some categories – e.g. several
mention behaviour; several mention coping and dealing
with tinnitus. I've tried my best to separate them.”
SOUND00147: “As a member of the public with
tinnitus a number of the questions were difficult to
understand and/or answer; either because the
language used was too technical or because it was
hard to see how it related to either tinnitus or the
treatment thereof.”
TALKC00188: “A little difficult to understand what
I'm being asked. Questions need to be more clear.”
Post-hoc analysis explored whether non-native English
language might be a barrier to participation, but ruled
out this possibility for the following reasons. First, 233
of the 719 participants declared that they did not speak
English as a native language (47 of these were patients).
Second, although there was an option to leave a com-
ment against each domain, we received very few com-
ments (n = 10) that were concerned with a lack of
understanding individual domains. Only four of those
were from people who did not have English as their first
language. For example, one French healthcare profes-
sional (SOUND00190) said “For a hearing-impaired per-
son this question may be ambiguous. One of his major
concern is to understand speech when noise is present in
his surrounding. Do what does “confusion” refers to? Does
it relate to the understanding of the conversation or clear
thoughts”. A full list of feedback comments gathered
during the first round of the Delphi survey can be found
in Additional file 1: Table S1.
High retention
Furthermore, there is no reason to believe that the
length of the long list was off putting to patient partici-
pants. First, attrition was very low. Of the 670 complet-
ing round 1, 586 also completed round 2, giving a 87%
overall retention rate. Retention was similar for patients
(305/358, 85%) as it was for professionals (281/312,
90%). Second, in round 1 only one negative comment
was received from a patient about the length of the
survey (SOUND00294 said “Too long... I just want some
help please”).
High retention of patients in the COMIT’ID Delphi
survey contrasts with a number of other COS studies in
which patients, more so than professionals, have with-
drawn across rounds 1 and 2. In one extreme example,
Al Wattar [30] reported 0% retention for patients (0/24)
compared with 68% for professionals (35/51). In another
example, the COS study [14] achieved a reasonable 78%
retention for patients (25/32), but not as good as the
91% for professionals (149/163).
Discussion
Patient involvement was an integral and transformative
step of the study design process. Through the inclusion
of Public Research Partners with lived experience of
tinnitus and a PPI/E Manager as three out of the nine
members of the Research Steering Group, the Study
Management Team co-produced a final long list com-
prising 66 outcome domains describing distinct tinnitus-
related complaints, with plain language domain names
and concise but understandable descriptions for each.
To the best of our knowledge, no previous COS studies
seem to report detailed public involvement methods for
optimising the long list of candidate outcome domains. It
is interesting to note that the recent COMET handbook
v1 [Section 2.9.1.3, 9] discusses the value of qualitative
research findings from patient interviews and focus
groups for ensuring that the outcome domain names and
explanations are understandable to patients, but does not
Table 2 Three illustrative examples of how input from patients informed changes in our descriptions to make them more
understandable and relevant to their experience of tinnitus
Outcome domain
name
Initial description Final description Explanation for the change
Confusion Feeling uncertain or unclear Being unable to think clearly,
either in general or specifically
associated with your tinnitus
Patients told us we needed to clarify what was causing the
confusion. We also had to be careful to distinguish from
another complaint called “worry/concerns” which also had
the word “uncertain” in its definition.
Tinnitus pitch Whether the tinnitus has a
high note or a low note
Whether your tinnitus has a
note-like quality, for example
high pitch like whistling or low
pitch like humming
Patients told us we needed to consider different values of
pitch so we broadened the description with examples.
Changed from “the tinnitus” to “your tinnitus” to make it
more personally directed.
Upset To be made unhappy by
tinnitus
Feeling unhappy or disappointed
because of your tinnitus
A patient recommended using the Oxford English Dictionary
definition. We also substituted “feeling” instead of “to be
made”, and added “because of your tinnitus” to make it more
personally directed.
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specifically mention the role of patient involvement in this
process. In this way, the procedures and insights described
in this article not only made valuable contributions to the
successful conduct of our Delphi survey, but also contrib-
ute to the broader methods literature by demonstrating
how patient involvement can enhance the accessibility of
the consensus processes.
This Discussion highlights seven general methodo-
logical features which the Research Steering Group feels
made a substantial difference and which fit with general
principles of good patient involvement. These recom-
mendations for effective patient involvement in refining
a long list of candidate outcome domains in a modified
Delphi survey are briefly explained below.
1. Planning: Plan what PPI steps are likely to have
most beneficial impact on the Core Outcome Set
project and incorporate them into the ethical
approval process.
Although ethical approval is not mandatory for
public involvement, setting out these steps in the
study protocol that was approved by the Research
Ethics Committee was a valuable element of our
project planning (see also [32]). By specifying the
roles of the Public Research Partners and other
healthcare users, it was possible to fully inform lay
members what was expected from them during the
recruitment process. While VC was an experienced
Public Research Partner with whom the Study
Management Team had worked previously, BT was
recruited to this role after responding to an
advertisement and completing an informal telephone
interview with HS. This approach would not have
been possible without prior planning. Second, by
clearly defining the public involvement roles it was
possible to budget appropriately for the associated
costs in the project. An additional grant was
subsequently obtained from the British Tinnitus
Association specifically to support the public
involvement component of the COS development,
and this application was led by the PPI/E Manager
and with one of the Public Research partners (VC)
as a co-applicant. Agreeing the roles of the lay
members and appropriate budgeting are two
recognised principles of good practice for successful
healthcare user involvement in National Health
Service research [33]. Moreover, involving the Public
Research Partners in the grant application and as
members of the Research Steering Group were
opportunities to formally acknowledge the
importance of their role.
2. Seeking relevant input: Appoint a small number of
Public Research Partners with lived experience of the
condition of interest, an eagerness to express their
opinions, and whom can provide continuity over a
number of face-to-face workshops. A PPI/E Manager
can be helpful in providing personal support and
mentorship.
The two Public Research Partners shared a
willingness to express their opinions and a sense of
humour. These were two positive personal qualities
that made the public involvement process enjoyable,
not only for the individuals involved but also for the
Study Management Team. It was helpful that the
Public Research Partners lived locally and were
retired because this made it possible for them to
provide continuity over a number of face-to-face
workshops. Personal access to internet and email
were also beneficial for sharing documentation
before and after the workshops, and as members of
the Research Steering Group. The involvement of
the PPI/E Manager was also useful in providing
personal support and mentorship, whenever
required. It can be reassuring to have a professional
member of the Research Steering Group who has
not been involved in designing the study, providing
an impartial contact for healthcare users and a
balance of perspectives. Again, provision of lay
support meets one of the principles of good public
involvement [33].
3. Being open-minded: Remain open minded, flexible,
and curious about the lay perspective.
In this study, public involvement was far from
tokenistic. The Study Management Team remained
open minded, flexible and curious about the lay
perspective. They were not simply expecting the
Public Research Partners to confirm the initial long
list of candidate outcome domains. In fact, by
respecting their knowledge and experience, the
Study Management Team welcomed the challenge
at the first workshop to reconsider the length of the
preliminary long list. The final long list of candidate
outcome domains was directly shaped in response to
this challenge. It was bespoke according to the needs
of the study as seen through the eyes of our Public
Research Partners and Lay Reviewers.
4. Careful reviewing: Review the preliminary long list
of candidate outcome domains in a face-to-face
workshop(s), focusing discussion on the names,
underlying theoretical constructs and plain language
descriptions of each one.
The face-to-face workshop format worked well in
enabling facilitated discussions about the underlying
theoretical constructs and plain language descriptions.
To maintain a balance of membership, a workshop
was convened with an equal number of researchers to
Public Research Partners. Having a PPI/E Manager
participate in the workshop was helpful in providing
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support to the Public Research Partners and
prompting the researchers when technical terms
required further explanation or when clarification was
needed. A single workshop was insufficient. After
3½ hours of discussion, there were still domains on
the preliminary long list which had not been
considered. Participation was an intense (and tiring)
experience and so a second workshop was planned to
complete the work. In hindsight, the Study
Management Team had perhaps been too ambitious
to expect to complete discussion of all 124 domains in
one meeting. This lesson has been taken on board
when planning the agenda for the final face-to-face
consensus meeting after the Delphi survey is
completed. Meaningful discussion on all 66 outcome
domains in the final long list is unlikely to be achieved
in a one-day meeting.
5. Note taking: Take notes and audio record the
workshop discussions for later reference.
Handwritten notes were important, but an audio
recording of the workshop discussions was
invaluable for later reference to jog the memory of
the researchers. Not all decisions about modifying
the long list were made in the workshops
themselves. The notes and audio recordings were
therefore important in assisting the Study
Management Team to reflect on the content of the
discussions and to make informed decisions without
any time pressures and also to reflect again on the
discussion to make sure that none of the researchers
were ‘putting words in the mouth’ of the Public
Research Partners. The audio recording was
particularly helpful to the member of the Study
Management Team (DAH) who was not present in
the workshops. It gave a retrospective yet accurate
record of who said what. The Study Management
Team also referred to the audio recording when
preparing this research report.
6. Reflecting: Reflect on the discussion and
recommendations as a Study Management Team
to create an interim long list.
Taking time outside the two Public Research Partner
workshops gave an important opportunity for the
Study Management Team to reflect on the discussion
and recommendations without feeling any undue time
pressures. Members of the Study Management Team
who did attend the workshop also found it helpful to
go over the main points of the conversation with their
fellow member who had not been present in the
workshop, so giving a new perspective.
7. Engaging wider feedback: Identify and engage a
diverse group to review the interim list of outcome
domain names and plain language descriptions, thus
creating a final long list.
Review of the interim long list by a reasonably broad
mix of patients and clinical experts increased our
confidence in the conceptual uniqueness of each
domain and personal relevance of each plain
language description. The experience in round 1 was
that none of the feedback challenged our grouping
or definitions of the candidate outcome domains.
From this the conclusion is that reducing the
overlap in the constructs corresponding to each
outcome domain at the preparatory stage reduced
the likelihood of Delphi participants recommending
changes to the long list. Rather than querying the
validity of the outcome domains themselves,
participants have focused on scoring importance. In
at least one preceding COS study, participant
feedback was found to challenge investigators to
exclude some overarching domains in between the
Delphi rounds [31]. It is uncertain whether this
earlier study incorporated patient involvement at the
preparatory stage.
The study findings suggested that non-native English
was not a barrier to participation in the English language
Delphi survey. Nevertheless, including patient involve-
ment with non-native English language speakers could
have brought additional benefits by enabling a more
representative group of people to comment on their
understanding of the outcome domain names and
descriptions. This limitation could have been overcome
by engaging the European professional members of the
Research Steering Group to lead some of the patient
involvement activities in their own countries, either in
the form of workshops or an online survey. Enlisting
patient involvement from those with a range of English
language abilities is just one aspect of diversity. Involving
people with a range of ages, ethnicity and socio-
economic status are other aspects to consider in future
work. The Study Management Team did not act on the
small number of negative participatory experiences that
were received in the round 1 feedback, due to resource
limitations and time pressures for opening round 2.
However, future work could consider a role for patient
involvement here, especially where comments pertain to
the understanding of specific outcome domain names
and descriptions.
The time spent developing a high-quality long list of
candidate outcome domains as preparation before the
Delphi process is anticipated to bring later benefits in the
face-to-face consensus meetings. Several COS study re-
ports show how considerable discussion time during the
consensus meeting has been taken up with queries about
consolidating outcome domains into larger categories, ex-
cluding some domains on the basis that they are more
relevant to how the domain is measured or that they are
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specific to one form of intervention, or sometimes even
redefining the outcome domains themselves. In one
example, during a COS consensus meeting for otitis
media with effusion in children with cleft palate, partici-
pants agreed to combine the outcome domain ‘consonant
production (cleft-related speech patterns)’ with ‘consonant
production’, and furthermore that both of these should
directly inform subsequent decisions of how to measure
‘speech development’ [13]. In another example, during a
COS consensus meeting for psoriatic arthritis, participants
agreed to redefine the outcome domain ‘emotional well-
being’ (feeling good about oneself ) so that it additionally
captured the outcome domains: ‘anxiety’, ‘depressive mood’,
‘embarrassment’, ‘frustration’, ‘self-worth’, and ‘stress’ [34].
For the COMIT’ID study, the Study Management
Team has pre-empted many of these discussions in the
preparatory phase, leaving greater opportunity for the
consensus meeting to focus on prioritising what should
be in the core set.
Conclusions
The end result of the public involvement process has been
a rich insight into the healthcare user perspective for the
design of a long list of candidate outcome domains for a
modified Delphi survey. This article describes procedures
and offers methodological guidance for working effectively
with patients to develop a mutual understanding of (often
complex) healthcare concepts, and to co-produce the final
long list with a set of plain language descriptions.
Although it is not possible to directly attribute study
performance to public involvement, the online Delphi
survey has been highly successful in terms of recruitment,
retention and accessibility. This experience confirms the
wide-ranging benefits of public involvement in reviewing
the long list before an online Delphi survey is launched.
Procedures recommended in this article go beyond core
outcome set development because they embody general
standards for good patient involvement that can be trans-
ferred into other research contexts.
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